Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT
Trial end date:
SummaryComparison of NEOVIST 370 INJ.(Iopromide 768.86mg) with Ultravist 370 INJ.(Iopromide 768.86mg) in abdominal CT
Accepts Healthy Volunteers?No
Seoul National University Hospital
- Aged 20 to 75 years old.
- Subjects who need CT scan
- Subjects who are willing to participate in the study and to write the informed consent
- Subjects with severe hepatopathy whose AST or ALT ≥ 1,000 IU/L, Subjects with liver
cirrhosis whose AST or ALT ≥ UNL(upper normal limit) X 3
- Severe disorder of thyroid gland
- pregnant or breastfeeding female subjects, or female subjects with childbearing
potential who are not willing to use proper contraception methods
- Participation in another clinical trial within 30days of enrollment into this study.